Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
. (2018) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 198-216.
Read now
Read now
MHD Rami Al Shweiki, Patrick Oeckl, Petra Steinacker, Bastian Hengerer, Carlos Schönfeldt-Lecuona & Markus Otto. (2017) Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies. Expert Review of Proteomics 14:6, pages 499-514.
Read now
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Read now
Kina Höglund & Hugh Salter. (2013) Molecular biomarkers of neurodegeneration. Expert Review of Molecular Diagnostics 13:8, pages 845-861.
Read now
Read now
Aleksandar Ignjatović, Zorica Stević, Dragana Lavrnić, Aleksandra Nikolić-Kokić, Duško Blagojević, Mihajlo Spasić & Ivan Spasojević. (2012) Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis 13:4, pages 357-362.
Read now
Read now
John W Rose & Noel G Carlson. (2011) Clinical biomarkers in multiple sclerosis. Expert Opinion on Medical Diagnostics 5:3, pages 213-226.
Read now
Read now
Kyoungho Suk. (2010) Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers. Expert Review of Proteomics 7:2, pages 263-274.
Read now
Read now
Hayrettin Tumani, Vera Lehmensiek, Stefan Lehnert, Markus Otto & Johannes Brettschneider. (2010) 2D DIGE of the cerebrospinal fluid proteome in neurological diseases. Expert Review of Proteomics 7:1, pages 29-38.
Read now
Read now
Articles from other publishers (63)
Ayushi Singhal, Rashmita Devi, Arpana Parihar & Raju Khan. 2024. Smart Diagnostics for Neurodegenerative Disorders. Smart Diagnostics for Neurodegenerative Disorders
61
80
.
Zachary Levin, Owen P Leary, Victor Mora, Shawn Kant, Sarah Brown, Konstantina Svokos, Umer Akbar, Thomas Serre, Petra Klinge, Alexander Fleischmann & Maria Grazia Ruocco. (2023) Cerebrospinal fluid transcripts may predict shunt surgery responses in normal pressure hydrocephalus. Brain 146:9, pages 3747-3759.
Crossref
Crossref
Sneha Ghildiyal, Manjari Baluni, D. Himanshu ReddyAlok Kumar. (2023) Comprehensive Assessment of Human Cerebrospinal Fluid for Protein Bio-Marker Identification Following Japanese Encephalitis Viral Infection. Biomedical and Pharmacology Journal 16:2, pages 797-807.
Crossref
Crossref
Giulia Coarelli & Alexandra Durr. 2023. Trials for Cerebellar Ataxias. Trials for Cerebellar Ataxias
379
392
.
Virginie Imbault, Chiara Dionisi, Gilles Naeije, David Communi & Massimo Pandolfo. (2022) Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation. Frontiers in Neuroscience 16.
Crossref
Crossref
Ahmed Abdelhak, Matteo Foschi, Samir Abu-Rumeileh, John K. Yue, Lucio D’Anna, Andre Huss, Patrick Oeckl, Albert C. Ludolph, Jens Kuhle, Axel Petzold, Geoffrey T. Manley, Ari J. Green, Markus Otto & Hayrettin Tumani. (2022) Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nature Reviews Neurology 18:3, pages 158-172.
Crossref
Crossref
Gi Su Yun, Yong Nam In, Changshin Kang, Jung Soo Park, Yeonho You, Jin Hong Min, Hong Joon Ahn, Insool Yoo, Seung Whan Kim, Se Kwang Oh, In Ho Lee & Da Mi Kim. (2022) Development of a strategy for assessing blood-brain barrier disruption using serum S100 calcium-binding protein B and neuron-specific enolase in early stage of neuroemergencies: A preliminary study. Medicine 101:28, pages e29644.
Crossref
Crossref
Andrés Caicedo, Kevin Zambrano, Serena Sanon & Antonio W.D. Gavilanes. (2021) Extracellular mitochondria in the cerebrospinal fluid (CSF): Potential types and key roles in central nervous system (CNS) physiology and pathogenesis. Mitochondrion 58, pages 255-269.
Crossref
Crossref
Byeong Gwan Cho, Cristian D. Gutierrez Reyes & Yehia Mechref. (2021) N-Glycomics of Cerebrospinal Fluid: Method Comparison. Molecules 26:6, pages 1712.
Crossref
Crossref
Hem Prakash Karki, Yeongseok Jang, Jinmu Jung & Jonghyun Oh. (2021) Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Ting Cao, NaNa Li & HuaLin Cai. (2020) Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?. Schizophrenia Research 226, pages 95-110.
Crossref
Crossref
Yoav Y. Broza, Xi Zhou, Miaomiao Yuan, Danyao Qu, Youbing Zheng, Rotem Vishinkin, Muhammad Khatib, Weiwei Wu & Hossam Haick. (2019) Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors. Chemical Reviews 119:22, pages 11761-11817.
Crossref
Crossref
Byeong Gwan Cho, Lucas Veillon & Yehia Mechref. (2019) N-Glycan Profile of Cerebrospinal Fluids from Alzheimer’s Disease Patients Using Liquid Chromatography with Mass Spectrometry. Journal of Proteome Research 18:10, pages 3770-3779.
Crossref
Crossref
Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas-Rodríguez, Marc Suárez-Calvet, Uwe K. Zettl, Christian Haass, Sven G. Meuth, Sebastian Rauer, Markus Otto, Hayrettin Tumani & André Huss. (2019) Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?. Frontiers in Neurology 10.
Crossref
Crossref
Sandra I. Anjo, Cátia Santa & Bruno Manadas. 2019. Cerebrospinal Fluid (CSF) Proteomics. Cerebrospinal Fluid (CSF) Proteomics
169
189
.
Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat & Hélène Blasco. (2018) Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. Frontiers in Neurology 9.
Crossref
Crossref
Yukiko Y. Lema, Nao J. Gamo, Kun Yang & Koko Ishizuka. (2018) Trait and state biomarkers for psychiatric disorders: Importance of infrastructure to bridge the gap between basic and clinical research and industry. Psychiatry and Clinical Neurosciences 72:7, pages 482-489.
Crossref
Crossref
Simone Poddighe, Federica Murgia, Lorena Lorefice, Sonia Liggi, Eleonora Cocco, Maria Giovanna Marrosu & Luigi Atzori. (2017) Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis. The International Journal of Biochemistry & Cell Biology 93, pages 148-155.
Crossref
Crossref
Eric Michel, Daniel Hernandez & Soo Yeol Lee. (2017)
Electrical conductivity and permittivity maps of brain tissues derived from water content based on T
1
-weighted acquisition
. Magnetic Resonance in Medicine 77:3, pages 1094-1103.
Crossref
Crossref
Medi KoriBusra AydınSemra UnalKazim Yalcin ArgaDilek Kazan. (2016) Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. OMICS: A Journal of Integrative Biology 20:11, pages 645-661.
Crossref
Crossref
Patrick Oeckl, Fabian Metzger, Magdalena Nagl, Christine A.F. von Arnim, Steffen Halbgebauer, Petra Steinacker, Albert C. Ludolph & Markus Otto. (2016) Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies. Molecular & Cellular Proteomics 15:10, pages 3126-3138.
Crossref
Crossref
Michael Thompson, Christophe Blaszykowski, Sonia Sheikh, Cesar Rodriguez-Emmenegger & Andres de los Santos Pereira. 2016. Biological Fluid–Surface Interactions in Detection and Medical Devices. Biological Fluid–Surface Interactions in Detection and Medical Devices
184
265
.
Brice Fermier, Hélène Blasco, Emmanuel Godat, Cinzia Bocca, Joseph Moënne-Loccoz, Patrick Emond, Christian Andres, Marc Laffon & Martine Ferrandière. (2016) Specific Metabolome Profile of Exhaled Breath Condensate in Patients with Shock and Respiratory Failure: A Pilot Study. Metabolites 6:3, pages 26.
Crossref
Crossref
Felix Benninger, Micaela J. Glat, Daniel Offen & Israel Steiner. (2016) Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 26, pages 75-78.
Crossref
Crossref
Payam Emami Khoonsari, Anna Häggmark, Maria Lönnberg, Maria Mikus, Lena Kilander, Lars Lannfelt, Jonas Bergquist, Martin Ingelsson, Peter Nilsson, Kim Kultima & Ganna Shevchenko. (2016) Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease. PLOS ONE 11:3, pages e0150672.
Crossref
Crossref
H. Blasco, F. Patin, B. Madji Hounoum, P. H. Gordon, P. Vourc'h, C. R. Andres & P. Corcia. (2016) Metabolomics in amyotrophic lateral sclerosis: how far can it take us?. European Journal of Neurology 23:3, pages 447-454.
Crossref
Crossref
Andreas A. Linninger, Kevin TangenChih-Yang HsuDavid Frim. (2016) Cerebrospinal Fluid Mechanics and Its Coupling to Cerebrovascular Dynamics. Annual Review of Fluid Mechanics 48:1, pages 219-257.
Crossref
Crossref
Erik Hessen, Arto Nordlund, Jacob Stålhammar, Marie Eckerström, Maria Bjerke, Carl Eckerström, Mattias Göthlin, Tormod Fladby, Ivar Reinvang & Anders Wallin. (2015) T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study. Journal of Alzheimer's Disease 47:3, pages 619-628.
Crossref
Crossref
Ahmed Abdelhak, Andreas Junker, Johannes Brettschneider, Jan Kassubek, Albert Ludolph, Markus Otto & Hayrettin Tumani. (2015) Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?. International Journal of Molecular Sciences 16:8, pages 17565-17588.
Crossref
Crossref
Ana Ugarte, Francisco Gil-Bea, Carolina García-Barroso, Ángel Cedazo-Minguez, M. Javier Ramírez, Rafael Franco, Ana García-Osta, Julen Oyarzabal & Mar Cuadrado-Tejedor. (2015) Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease. Neuropathology and Applied Neurobiology 41:4, pages 471-482.
Crossref
Crossref
Sonia A. van der Sar, Ronald Zielman, Gisela M. Terwindt, Arn M. J. M. van den Maagdenberg, André M. Deelder, Oleg A. Mayboroda, Axel Meissner & Michel D. Ferrari. (2015) Ethanol contamination of cerebrospinal fluid during standardized sampling and its effect on 1H-NMR metabolomics. Analytical and Bioanalytical Chemistry 407:16, pages 4835-4839.
Crossref
Crossref
Ashley M. Brouillette, Gülin Öz & Christopher M. Gomez. (2015) Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study. Disease Markers 2015, pages 1-6.
Crossref
Crossref
Christophe Blaszykowski, Sonia Sheikh & Michael Thompson. (2015) A survey of state-of-the-art surface chemistries to minimize fouling from human and animal biofluids. Biomaterials Science 3:10, pages 1335-1370.
Crossref
Crossref
Sandra Amor, Baukje J van der Star, Isabel Bosca, Joel Raffel, Sharmilee Gnanapavan, Jonathan Watchorn, Jens Kuhle, Gavin Giovannoni, David Baker, Andrea Malaspina & Fabiola Puentes. (2014) Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis. Multiple Sclerosis Journal 20:10, pages 1355-1362.
Crossref
Crossref
P. Martin-Vaquero, R.C. da Costa, S.A. Moore, A.C. Gross & T.D. Eubank. (2014) Cytokine Concentrations in the Cerebrospinal Fluid of Great Danes with Cervical Spondylomyelopathy. Journal of Veterinary Internal Medicine 28:4, pages 1268-1274.
Crossref
Crossref
Intan N. F. Shafie, Mark McLaughlin, Richard Burchmore, Mary Ann A. Lim, Paul Montague, Pamela E. J. Johnston, Jacques Penderis & Thomas J. Anderson. (2013) The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog. Cell Stress and Chaperones 19:3, pages 311-320.
Crossref
Crossref
Hélène BlascoLydie Nadal-DesbaratsPierre-François PradatPaul H. GordonCatherine AntarCharlotte Veyrat-DurebexCaroline MoreauDavid DevosSylvie MavelPatrick EmondChristian R. AndresPhilippe Corcia. (2014)
Untargeted
1
H-NMR metabolomics in CSF
. Neurology 82:13, pages 1167-1174.
Crossref
Crossref
Hassan A. N. El-Fawal. (2014) Neuroantibody Biomarkers: Links and Challenges in Environmental Neurodegeneration and Autoimmunity. Autoimmune Diseases 2014, pages 1-12.
Crossref
Crossref
Hélène Blasco, Philippe CorciaPaul H Gordon & Pierre-François Pradat. (2013) Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond. Neurodegenerative Disease Management 3:5, pages 427-444.
Crossref
Crossref
Hélène Blasco, Philippe Corcia, Pierre-François Pradat, Cinzia Bocca, Paul H. Gordon, Charlotte Veyrat-Durebex, Sylvie Mavel, Lydie Nadal-Desbarats, Caroline Moreau, David Devos, Christian R. Andres & Patrick Emond. (2013) Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry. Journal of Proteome Research 12:8, pages 3746-3754.
Crossref
Crossref
R. M. Liscic, K. Srulijes, A. Gröger, W. Maetzler & D. Berg. (2013) Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools. Acta Neurologica Scandinavica 127:5, pages 362-370.
Crossref
Crossref
Alok Kumar, Devlina Ghosh & R. L. Singh. (2013) Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach. Journal of Biomarkers 2013, pages 1-15.
Crossref
Crossref
Thomas Krüger, Janin Lautenschläger, Julian Grosskreutz & Heidrun Rhode. (2013) Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. PROTEOMICS – Clinical Applications 7:1-2, pages 123-135.
Crossref
Crossref
Ales Bartos, Lenka Fialová, Jana Švarcová & Daniela Ripova. (2012) Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament. Journal of Neuroimmunology 252:1-2, pages 100-105.
Crossref
Crossref
Nenad Vasic, Bernhard J. Connemann, Robert C. Wolf, Hayrettin Tumani & Johannes Brettschneider. (2011) Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?. European Archives of Psychiatry and Clinical Neuroscience 262:5, pages 375-391.
Crossref
Crossref
Joanna Tarasiuk, Alina Kułakowska, Wiesław Drozdowski, Johannes Kornhuber & Piotr Lewczuk. (2012) CSF markers in amyotrophic lateral sclerosis. Journal of Neural Transmission 119:7, pages 747-757.
Crossref
Crossref
Hong I Wan, Holly Soares & Jeffrey F Waring. (2012) Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression. Biomarkers in Medicine 6:1, pages 119-129.
Crossref
Crossref
Petra Steinacker, Lubin Fang, Jens Kuhle, Axel Petzold, Hayrettin Tumani, Albert C. Ludolph, Markus Otto & Johannes Brettschneider. (2011) Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis. PLoS ONE 6:8, pages e23600.
Crossref
Crossref
Nobutoshi Morimoto, Kentaro Deguchi, Kota Sato, Taijun Yunoki, Shoko Deguchi, Yasuyuki Ohta, Tomoko Kurata, Yoshiki Takao, Yoshio Ikeda, Tohru Matsuura & Koji Abe. (2011) Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS. Journal of the Neurological Sciences 307:1-2, pages 74-78.
Crossref
Crossref
Dorothy G. Flood, Gerard J. Marek & Michael Williams. (2011) Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine. Biochemical Pharmacology 81:12, pages 1422-1434.
Crossref
Crossref
Sarah Jesse, Johannes Brettschneider, Sigurd D. Süssmuth, Bernhard G. Landwehrmeyer, Christine A. F. Arnim, Albert C. Ludolph, Hayrettin Tumani & Markus Otto. (2010) Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. Journal of Neurology 258:6, pages 1034-1041.
Crossref
Crossref
Johann Steiner, Bernhard Bogerts, Matthias L. Schroeter & Hans-Gert Bernstein. (2011) S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine 49:3.
Crossref
Crossref
Johannes BrettschneiderNele HartmannVera LehmensiekHelga MogelAlbert C LudolphHayrettin Tumani. (2010) Cerebrospinal fluid markers of idiopathic intracranial hypertension: Is the renin-angiotensinogen system involved?. Cephalalgia 31:1, pages 116-121.
Crossref
Crossref
Irena Dujmovic. (2011) Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis. Multiple Sclerosis International 2011, pages 1-18.
Crossref
Crossref
Hélène Blasco, Philippe Corcia, Caroline Moreau, Ségolène Veau, Clémentine Fournier, Patrick Vourc'h, Patrick Emond, Paul Gordon, Pierre-François Pradat, Julien Praline, David Devos, Lydie Nadal-Desbarats & Christian R. Andres. (2010) 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis. PLoS ONE 5:10, pages e13223.
Crossref
Crossref
Armin Scheurich, Peter P. Urban, Nassrin Koch-Khoury & Andreas Fellgiebel. (2009) CSF phospho-tau is independent of age, cognitive status and gender of neurological patients. Journal of Neurology 257:4, pages 609-614.
Crossref
Crossref
Johannes Brettschneider, Vera Lehmensiek, Helga Mogel, Martin Pfeifle, Johannes Dorst, Corinna Hendrich, Albert C. Ludolph & Hayrettin Tumani. (2010) Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neuroscience Letters 468:1, pages 23-27.
Crossref
Crossref
Hyejin Hwang, Jianpeng Zhang, Kathryn A. Chung, James B. Leverenz, Cyrus P. Zabetian, Elaine R. Peskind, Joseph Jankovic, Zhen Su, Aneeka M. Hancock, Catherine Pan, Thomas J. Montine, Sheng Pan, John Nutt, Roger Albin, Marla Gearing, Richard P. Beyer, Min Shi & Jing Zhang. (2010) Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews 29:1, pages 79-125.
Crossref
Crossref
M Podbielska & EL Hogan. (2009) Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?. Multiple Sclerosis Journal 15:9, pages 1011-1029.
Crossref
Crossref
Hayrettin Tumani, Hans-Peter Hartung, Bernhard Hemmer, Charlotte Teunissen, Florian Deisenhammer, Gavin Giovannoni & Uwe K. Zettl. (2009) Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiology of Disease 35:2, pages 117-127.
Crossref
Crossref
H. Tumani, V. Lehmensiek, D. Rau, I. Guttmann, G. Tauscher, H. Mogel, C. Palm, V. Hirt, S.D. Suessmuth, I. Sapunova-Meier, A.C. Ludolph & J. Brettschneider. (2009) CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis. Neuroscience Letters 452:2, pages 214-217.
Crossref
Crossref
Hayrettin Tumani & Manfred W. Wick. 2009. Das Laborbuch. Das Laborbuch
321
349
.
Georgene W. Hergenroeder, John B. Redell, Anthony N. Moore & Pramod K. Dash. (2012) Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury. Molecular Diagnosis & Therapy 12:6, pages 345-358.
Crossref
Crossref